<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39018475</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0987</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>The Pediatric infectious disease journal</Title><ISOAbbreviation>Pediatr Infect Dis J</ISOAbbreviation></Journal><ArticleTitle>Circulating Activated Platelets in Children With Long Covid: A Case-Controlled Preliminary Observation.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/INF.0000000000004470</ELocationID><Abstract><AbstractText>We investigated if children with Long Covid (n=14) have activated platelets compared with healthy controls (n=14). Platelet activation and secretion markers were investigated by flow cytometry using MoAbs directed against P-selectin, CD63, and PAC-1 in quiescent platelets and in platelets stimulated with 10-&#xb5;M adenosine diphosphate and 25-&#xb5;M protease activated receptor 1-activating peptide. Circulating platelets of patients with Long Covid had significantly increased expression of the activation marker cytometry using MoAbs directed against P-selectin (P = 0.019).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8567-2639</Identifier><AffiliationInfo><Affiliation>From the Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro di Salute Globale, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorrentino</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze di Laboratorio ed Ematologiche, Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferretti</LastName><ForeName>Antonietta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze di Laboratorio ed Ematologiche, Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Gennaro</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze di Laboratorio ed Ematologiche, Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Medicina e Chirurgia Traslazionale, Universit&#xe0; Cattolica del Sacro Cuore, Facolt&#xe0; di Medicina, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Candia</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze di Laboratorio ed Ematologiche, Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Medicina e Chirurgia Traslazionale, Universit&#xe0; Cattolica del Sacro Cuore, Facolt&#xe0; di Medicina, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Infect Dis J</MedlineTA><NlmUniqueID>8701858</NlmUniqueID><ISSNLinking>0891-3668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>The remaining authors have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>15</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39018475</ArticleId><ArticleId IdType="doi">10.1097/INF.0000000000004470</ArticleId><ArticleId IdType="pii">00006454-990000000-00947</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turner S, Khan MA, Putrino D, et al. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34:321&#x2013;344.</Citation></Reference><Reference><Citation>Cervia-Hasler C, Br&#xfc;ningk SC, Hoch T, et al. Persistent complement dysregulation with signs of thromboinflammation in active long Covid. Science. 2024;383:eadg7942.</Citation></Reference><Reference><Citation>Wang SSY, Chee K, Wong SW, et al.; COVID-19 Clotting and Bleeding Investigators. COVID-19 clotting and bleeding investigators. increased platelet activation demonstrated by elevated CD36 and P-Selectin expression in 1-year post-recovered COVID-19 patients. Semin Thromb Hemost. 2023;49:561&#x2013;564.</Citation></Reference><Reference><Citation>Rao S, Gross RS, Mohandas S, et al. Postacute sequelae of SARS-CoV-2 in children. Pediatrics. 2024;153:e2023062570.</Citation></Reference><Reference><Citation>Morello R, Mariani F, Mastrantoni L, et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. EClinicalMedicine. 2023;59:101961.</Citation></Reference><Reference><Citation>https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1. Accessed on April 24, 2024</Citation></Reference><Reference><Citation>Seylanova N, Chernyavskaya A, Degtyareva N, et al.; PC-COS Children Study Group. Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international delphi consensus study &#x201c;PC-COS Children.&#x201d;. Eur Respir J. 2024;63:2301761.</Citation></Reference><Reference><Citation>Di Gennaro L, Valentini P, Sorrentino S, et al. Extended coagulation profile of children with Long Covid: a prospective study. Sci Rep. 2022;12:18392.</Citation></Reference><Reference><Citation>Buonsenso D, Valentini P, De Rose C, et al. On Behalf Of The Gemelli-Pediatric Covid-Team. Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children. J Clin Med. 2022;11:4363.</Citation></Reference><Reference><Citation>https://www.croiconference.org/wp-content/uploads/sites/2/posters/2024/347.pdf. Accessed on May 2, 2024.</Citation></Reference><Reference><Citation>Boever J, Nussbaum C, Arnold L, et al. Long-term microvascular changes in multisystem inflammatory syndrome in children. JAMA Pediatr. 2024;178:304&#x2013;306.</Citation></Reference><Reference><Citation>Chen Y, Zhong H, Zhao Y, et al. Role of platelet biomarkers in inflammatory response. Biomark Res. 2020;8:28.</Citation></Reference><Reference><Citation>Laubscher GJ, Khan MA, Venter C., et al. Treatment of Long COVID symptoms with triple anticoagulant therapy, 21 March 2023, PREPRINT (Version 1) available at Research Square.</Citation></Reference><Reference><Citation>Connors JM, Ari&#xeb;ns RAS. Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Thromb Haemost. 2023;21:2697&#x2013;2701.</Citation></Reference><Reference><Citation>Connors JM, Ari&#xeb;ns RAS. Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection-response to the letter by Kell et al. J Thromb Haemost. 2024;22:569&#x2013;571.</Citation></Reference><Reference><Citation>Buonsenso D, Di Giuda D, Sigfrid L, et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health. 2021;5:677&#x2013;680.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>